Jump to content
Powered by BIOPRO BW
  • BIOPRO BW
  • Healthcare industry
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
Healthcare industry Logo

Main navigation

  • Start page Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close Close
  • Databases

    Databases

    Close Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 16/11/2026

    AI and life sciences: two new research training groups at Universität Heidelberg

    Heidelberg University has been successful in the current approval round of the German Research Foundation with two applications for the funding of Research Training Groups. RTG 3251 “From Omics to Mechanisms”, which is located in the life sciences, seeks to develop new methods of obtaining, analyzing and interpreting extensive biological datasets. Research Training Group 3270 “Generative AI in the Sciences” focuses on artificial intelligence.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ai-and-life-sciences-two-new-research-training-groups-universitaet-heidelberg
  • Press release - 12/11/2026

    DKFZ Sets Records for ERC Synergy Grants

    A historic success for the German Cancer Research Center (DKFZ): Four DKFZ researchers are receiving one of the prestigious ERC Synergy Grants this year—more than ever before at a single institution in a single funding round. Three of the four international research consortia are coordinated by the DKFZ. In total, the projects will receive approximately 44.5 million euros, of which about 13.7 million euros will go to the DKFZ.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/dkfz-sets-records-erc-synergy-grants
  • Press release - 12/11/2026

    Universität Heidelberg and Harvard university mark the launch of their strategic partnership

    With a strategic partnership, Heidelberg and Harvard University are expanding their academic relationships, strengthening transatlantic networks and promoting excellent research.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/universitaet-heidelberg-and-harvard-university-mark-launch-their-strategic-partnership
  • Press release - 11/11/2026

    Spine tumor surgery: Better preparation with a digital twin

    How can complex spinal tumor surgeries be planned and prepared more effectively in the future? As part of the IntelliSpine-Recon collaborative project, researchers will develop, among other innovations, a digital twin of the spine and a virtual training environment for surgeons. The junior research consortium, coordinated by the Heidelberg Faculty of Medicine at Heidelberg University, is being carried out in partnership with the KIT.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/spine-tumor-surgery-better-preparation-digital-twin
  • Press release - 02/11/2026

    Heidelberger researchers receive Else Kröner memorial fellowships for projects on kidney disease and AI-based diagnostics

    Why do certain congenital kidney disorders vary so widely in severity among affected individuals? Can AI improve breast cancer diagnostics? These are the questions being addressed in current projects by two early-career researchers at the Heidelberg Faculty of Medicine at Heidelberg University.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberger-researchers-receive-else-kroner-memorial-fellowships-projects-kidney-disease-and-ai-based-diagnostics
  • Press release - 29/10/2026

    VUSE XR closes €1.2 million pre-seed round to scale enterprise mixed reality training

    VUSE XR today announced the closing of a €1.2 million pre-seed financing round led by IACD, a Düsseldorf-based business angel network. The company develops the VUSE XR Hub, an enterprise software solution for creating and deploying mixed reality training for industrial and life sciences companies.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/vuse-xr-closes-euro-12-million-pre-seed-round-scale-enterprise-mixed-reality-training
  • Press release - 20/10/2026

    How randomness makes artificial vision more reliable

    Humans are usually remarkably good at recognising objects, even under poor viewing conditions. Artificial vision systems, by contrast, reach their limits more quickly when images are distorted or unfamiliar. Researchers at the Hertie Institute for Clinical Brain Research (HIH) have now investigated what artificial vision systems can learn from the brain.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-randomness-makes-artificial-vision-more-reliable
  • Press release - 16/10/2026

    A new approach to osteoporosis treatment Disabling a bone formation inhibiting protein molecule

    How can the human body be stimulated to build more bone, thus helping those affected by osteoporosis? Researchers in Ulm have investigated the role played by the protein molecule Axl in this process. Their efforts were successful: in a study, they demonstrated that Axl inhibits bone formation – and that cells produce significantly more bone tissue when the molecule is blocked using medication. There are no discernible harmful side effects.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-approach-osteoporosis-treatment-disabling-bone-formation-inhibiting-protein-molecule
  • Press release - 16/10/2026

    Epilepsy: AI Aims to Improve Treatment with Brain Pacemakers

    About 250,000 people in Germany live with epilepsy that does not respond adequately to medication. How can their treatment be further improved with a brain pacemaker? As part of the CLOUDIA research project, the Medical Center – University of Freiburg is now collaborating with a medical technology company to develop an AI-supported assistance system for analyzing long-term brain activity data.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/epilepsy-ai-aims-improve-treatment-brain-pacemakers
  • Press release - 15/10/2026

    Four Million Euros in EU Funding to Improve Prostate Cancer Care

    A European research consortium led by the German Cancer Research Center (DKFZ) aims to fundamentally improve the diagnosis and treatment of prostate cancer using AI agents, big data, and patient-centered clinical decision support. The central goal is to detect aggressive tumors early and accurately, reduce unnecessary interventions, and tailor treatment decisions more closely to the individual patient.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/four-million-euros-eu-funding-improve-prostate-cancer-care
  • Press release - 06/10/2026

    EXIST funding for xenko start-up team at Ulm University Virtual health platform to encourage more physical activity in the working day

    The start-up xenko has been awarded an EXIST grant of 143,500 € from the Federal Ministry for Economic Affairs and Energy. The team of founders from Ulm University is developing a digital health platform designed to encourage more physical activity in everyday working life through virtual reality. This development is of interest to companies with occupational health management schemes and, in the long term, to the physiotherapy sector as well.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/exist-funding-xenko-start-team-ulm-university-virtual-health-platform-encourage-more-physical-activity-working-day
  • Press release - 06/10/2026

    Harnessing Synthetic Cellular Systems as Immune Cell Boosters

    How can cell-based immunotherapies for cancer and autoimmune diseases become more widely available in the long term? The SYNTHIA project is addressing this challenge: The Max Planck Institute for Medical Research and the Fraunhofer Institute for Cell Therapy and Immunology IZI are collaborating on new research approaches to advance the development of cell-based immunotherapies.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/harnessing-synthetic-cellular-systems-immune-cell-boosters
  • Press release - 05/10/2026

    A Matter of Quantity: A Universal Target for CAR-T Cells Against Cancer

    CAR-T cell therapies have proven successful in treating several types of blood and lymphoid cancers. However, their use in treating other tumors is significantly more challenging, in part because suitable target structures are lacking.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/matter-quantity-universal-target-car-t-cells-against-cancer-1
  • Press release - 05/10/2026

    A Matter of Quantity: A Universal Target for CAR-T Cells Against Cancer

    CAR-T cell therapies have proven successful in treating several types of blood and lymphoid cancers. However, their use in treating other tumors is significantly more challenging, in part because suitable target structures are lacking.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/matter-quantity-universal-target-car-t-cells-against-cancer
  • Press release - 01/10/2026

    New AI Agent to Capture and Analyze Patient Experiences for Healthcare Delivery and Health Systems

    An international consortium led by researchers at the Heidelberg Faculty of Medicine at Heidelberg University will develop an AI-powered interactive assistant for the analysis of patient experiences over the next four years. The goal is to identify individual burdens and challenges early and comprehensively and make this information actionable for patients, care teams, and health systems.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-ai-agent-capture-and-analyze-patient-experiences-healthcare-delivery-and-health-systems
  • Press release - 30/09/2026

    How cells pass on regulatory information

    A project funded by the Baden-Württemberg Stiftung at the Max Planck Institute of Immunobiology and Epigenetics in Freiburg is investigating the interplay between RNA modifications and epigenetic mechanisms during cell division – and its potential significance for treatment resistance in cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-cells-pass-regulatory-information
  • Press release - 23/09/2026

    ViferaXS Raises €12 Million to Advance Phase II Trial in Chronic Lymphocytic Leukemia and Expand Its Oncology Pipeline

    ViferaXS, a clinical-stage biotechnology company developing peptide-based cancer immunotherapy for hematologic malignancies and solid tumors, today announced the close of the Series A financing round of up to €12 million, including grant funding. The round was led by SPRIND, the German Federal Agency for Breakthrough Innovation, and Huma, with participation from private investors.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/viferaxs-raises-euro-12-million-advance-phase-ii-trial-chronic-lymphocytic-leukemia-and-expand-its-oncology-pipeline
  • Press release - 17/09/2026

    New technique could make MRI more precise

    A team of researchers at the University of Stuttgart has developed a new method that could make MRI even more precise by eliminating “dead time,” a key limiting factor in the measurement process, thereby enabling the detection of signals that are lost using conventional methods. This method opens up new possibilities for medical diagnostics and non-destructive materials testing. The research team presents the new approach in Science Advances.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-technique-could-make-mri-more-precise
  • Press release - 16/09/2026

    Professor Jakob Nikolas Kather Appointed Hopp Foundation Professor of “Artificial Intelligence in Medicine” and Founding Director of the New Institute for Medical AI (IMAI) in Heidelberg

    Effective 1 October 2026, Professor Jakob Nikolas Kather will assume the Hopp Foundation Professorship for “Artificial Intelligence in Medicine” at the Heidelberg Faculty of Medicine at Heidelberg University. Associated with the professorship is the establishment of the new Institute for Medical AI (IMAI) at Heidelberg University Hospital, which Professor Kather will lead as its founding director.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/professor-jakob-nikolas-kather-appointed-hopp-foundation-professor-artificial-intelligence-medicine-and-founding-director-new-in
  • Press release - 09/09/2026

    International Research on Bioengineering of the Mitochondrial Genome

    While the cell nucleus contains almost all of the genome, the mitochondria – the powerhouses of the cell – have their own small genetic code. It consists of only 37 genes, which are organized in circular DNA – mtDNA, for short. Defects in the mitochondrial genome are related to incurable neurodegenerative and metabolic diseases, cancer and also aging processes.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/international-research-bioengineering-mitochondrial-genome
  • Press release - 08/09/2026

    Heisenberg Professorship for Aurélie Ernst

    With funding from the German Research Foundation’s (DFG) Heisenberg Program, DKFZ researcher Aurélie Ernst aims to investigate how massive changes in the genome contribute to the development of cancer. Her research focuses on a phenomenon known as chromothripsis - a catastrophic event in the genome in which chromosomes break apart and are reassembled incorrectly.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/heisenberg-professorship-aurelie-ernst
  • Press release - 03/09/2026

    Triple ERC Success at the German Cancer Research Center

    Three researchers at the German Cancer Research Center (DKFZ) have each been awarded a Starting Grant from the European Research Council (ERC) this year. Daniel Kirschenbaum, Lena Kutscher, and Michael Scherer impressed the ERC with their innovative research approaches to fundamental questions in cancer medicine.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/triple-erc-success-german-cancer-research-center
  • Press release - 03/09/2026

    ERC Starting Grant for Heidelberg Neurologist and Neuroscientist Dr. Dr. Varun Venkataramani

    Cells of the highly aggressive brain tumor glioblastoma exhibit predatory behavior: they exploit signaling between healthy neurons and internalize portions of their contact sites. Dr. Dr. Varun Venkataramani of the Heidelberg Medical Faculty of Heidelberg University, and his research team, will investigate how glioblastoma cells benefit from this process and whether it may represent a novel therapeutic target.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/erc-starting-grant-heidelberg-neurologist-and-neuroscientist-dr-dr-varun-venkataramani
  • Funding

    FIGHT KIDS CANCER 2026-2027 Competitive Call

    Funding programme, Funded by: Fight Kids Cancer, sb_search.searchresult.label.programSubmissionDate: 13/10/2026
    https://www.gesundheitsindustrie-bw.de/en/database/funding/fight-kids-cancer-2026-2027-competitive-call
  • Press release - 28/08/2026

    Outstanding success for Ulm’s quantum physics QuantERA funds four teams

    Research into quantum technology by four teams at Ulm University is being funded as part of the European QuantERA programme. This is more than at any other German university. The projects focus, for example, on more robust quantum computers and innovative medical diagnostic methods.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/outstanding-success-ulms-quantum-physics-quantera-funds-four-teams

Page 1 / 12

sb_search.block.search_result.other.pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 12
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
  • Portals
    • BIOPRO BW
    • Healthcare industry
  • To top

stay informed

Newsletter abonnieren

Social Media

  • Xing Xing
  • Twitter visit Twitter
  • LinkedIn visit LinkedIn
  • Rss visit RSS
  • Privacy statement
  • Accessability Declaration
  • Legal notice
  • Sitemap
  • Contact
© 2026
Website address: https://www.gesundheitsindustrie-bw.de/en/search